Scope Ratings bekrefter A- /Stable outlook for Aurskog Sparebank
Ratingbyrået Scope Ratings har i dag publisert sin oppdaterte rating av Aurskog Sparebank.
Utsteder-rating og rating av bankens senior usikrede gjeld opprettholdes med A- og «stable outlook».
Vedlagt følger rapporten fra Scope Ratings for Aurskog Sparebank.
Kontaktpersoner:
Administrerende banksjef Evy Ann Hagen, telefon 906 74 709 eller
CFO/banksjef Andreas Halvorsrud Glende, telefon 481 16 695.
Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12.
Vedlegg
Hvis du vil se dette innholdet fra www.globenewswire.com, gi ditt samtykke øverst på denne siden.Hvis du vil se dette innholdet fra ml-eu.globenewswire.com, gi ditt samtykke øverst på denne siden.
Om GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg pressemeldinger fra GlobeNewswire by notified
Registrer deg med din e-postadresse under for å få de nyeste sakene fra GlobeNewswire by notified på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra GlobeNewswire by notified
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 20236.6.2023 09:00:00 CEST | Press release
Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their automated workflow solutions for streamlining discovery workflows in antibody and therapeutics development at Antibody Engineering and Therapeutics, Europe in Amsterdam, The Netherlands. In addition to the exhibition, Jason Lehmann, PhD Senior Product Marketing Manager at Telesis Bio will present “The BioXp® System: Accelerating Hit-to-Lead Discovery by Breaking Through Critical Synthesis Bottlenecks” in the opening day session. The award winning BioXp® system and associated BioXp De novo kits and BioXp Select kits enable push-button, automated synthesis of gene fragments, clones, variant libraries and mRNA from input sequence or existing DNA. In May, Telesis Bio also introduced their first automated NG
Anmodning om suspension for afdelinger under Investeringsforeningen BankInvest6.6.2023 09:00:00 CEST | pressemeddelelse
København K, June 06, 2023 (GLOBE NEWSWIRE) -- På grund af lokale lukkedage i de underliggende markeder anmodes om suspension af nedenstående afdelinger. AfdelingISINShort nameEuropa Small Cap Aktier ADK0060571362BAIESCAEmerging Markets Aktier ADK0060516854BAIEMAA Hvis der er spørgsmål, kontakt da Teamleder for Fund Valuation, Peter Akstrup, telefon 77 30 90 31. Med venlig hilsen BI Management A/S Martin Fjordlund Smidt Direktør
Aktietilbagekøbsprogram - uge 226.6.2023 08:56:45 CEST | pressemeddelelse
Nasdaq Copenhagen London Stock Exchange Euronext Dublin Øvrige interessenter Dato 06.06.2023 Aktietilbagekøbsprogram - uge 22 Aktietilbagekøbsprogrammet løber i perioden fra og med den 2. februar 2023 til og med den 27. juli 2023. I denne periode vil Ringkjøbing Landbobank tilbagekøbe aktier for en maksimal markedsværdi af 385 mio. kroner i et aktietilbagekøbsprogram, jf. selskabsmeddelelse af 1. februar 2023. Programmet gennemføres i henhold til EU-Kommissionens forordning nr. 596/2014 af 16. april 2014 og EU-Kommissionens delegerede forordning nr. 2016/1052 af 8. marts 2016, der tilsammen udgør ”Safe Harbour”-reguleringen. Følgende transaktioner er foretaget under aktietilbagekøbsprogrammet: DatoAntal aktier (stk.)Gennemsnitlig købspris (kroner)Tilbagekøbt i alt underprogrammet (kroner)I alt i henhold til seneste meddelelse 338.300 984,71 333.126.446 29. maj 202330. maj 20233.700928,283.434.63631. maj 20233.600930,003.348.00001. juni 20233.500934,903.272.15002. juni 20232.500950,362.
Share buy-back programme - week 226.6.2023 08:56:45 CEST | Press release
Nasdaq Copenhagen London Stock Exchange Euronext Dublin Other stakeholders Date 06.06.2023 Share buy-back programme - week 22 The share buy-back programme runs from and including 2 February 2023 up to and including 27 July 2023. During this period Ringkjøbing Landbobank will buy-back shares to a maximum market value of DKK 385 million under a share buy-back programme, see company announcement of 1 February 2023. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been made under the programme: DateNumber of sharesAverage purchase price (DKK)Total purchased under the programme (DKK)Total in accordance with the last announcement338,300 984.71333,126,44629. May 202330. May 20233,700928.283,434,63631. May 20233,600930.003,348,00001. June 20233,500934.903,272,15002. June 20232,500950.
Ensurge Micropower ASA Q&A session6.6.2023 08:55:00 CEST | Press release
With reference to the announcement 31 May, 2023, and the presentation held Monday 5 June, 2023, a recording of the presentation can be accessed by the link below. https://attendee.gotowebinar.com/recording/2395703227625088771 We have also attached an updated Investor presentation. About Ensurge Micropower Ensurge is Energizing Innovation(TM) with the first ultrathin, flexible, reliable, and fundamentally safe solid-state lithium microbattery for the 1 to 100 milliampere-hour (mAh) class of wearable devices, connected sensors, and beyond. The innovative Ensurge Microbattery enables energy-dense rechargeable products that are ideal for form-factor-constrained applications including hearables (hearing aids and wireless headphones), digital and health wearables, sports and fitness devices, and IoT sensor solutions that use energy harvesting to power everyday things. The company's state-of-the-art manufacturing facility, located in the heart of Silicon Valley, combines patented process tech